Copyright
©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 826-840
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.826
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.826
Intervention (n = 120) | Standard of care (n = 120) | P value | |
Patient demographics | |||
Age (mean ± SD) | 56.54 ± 11.21 | 56.14 ± 11.21 | 0.78 |
Age group | |||
65+ | 32, 26.67 | 28, 23.33 | 0.79 |
40-64 | 75, 62.50 | 80, 66.67 | |
18-39 | 13, 10.83 | 12, 10.00 | |
Gender | |||
Male | 60, 50.00 | 75, 62.50 | 0.03 |
Female | 60, 50.00 | 45, 32.50 | |
Race | |||
White | 105, 87.50 | 97, 80.83 | 0.22 |
Other | 15, 12.50 | 23, 19.17 | |
Ethnicity | |||
Not Hispanic or latino | 113, 94.17 | 114, 95.00 | 0.81 |
Hispanic or latino | 3, 2.50 | 1, 0.83 | |
Unknown / Not reported | 4, 3.33 | 5, 4.17 | |
Zip code income (mean ± SD) | $68045 ± $21370 | $68455 ± $21651 | 0.88 |
Employment status | |||
Unemployed | 33, 27.50 | 30, 25.00 | 0.78 |
Disabled | 24, 20.00 | 24, 20.00 | |
Retired | 26, 21.67 | 30, 20.00 | |
Employed, part time | 5, 4.17 | 3, 2.50 | |
Employed, full time | 23, 19.17 | 28, 23.33 | |
Other / Unknown | 9, 7.50 | 14, 11.67 | |
Insurance type | |||
Self-pay | 4, 3.33 | 3, 2.50 | 0.54 |
No Charge / Other / Unknown | 7, 5.83 | 7, 5.83 | |
Private insurance | 38, 31.67 | 35, 29.17 | |
Medicare | 32, 26.67 | 44, 36.67 | |
Medicaid | 39, 32.50 | 31, 25.83 | |
Number of admissions at OSU for DC in last 1 year (mean ± SD) | 1.99 ± 1.61 | 1.84 ± 1.48 | 0.45 |
MELD-Na score admit (mean ± SD) | 21.32 ± 8.19 | 22.47 ± 7.85 | 0.27 |
MELD-Na score discharge (mean ± SD, n = 117+118) | 20.07 ± 7.74 | 20.25 ± 6.93 | 0.84 |
CTP score admit (mean ± SD) | 9.31 ± 2.02 | 9.41 ± 1.89 | 0.69 |
CTP score discharge (mean ± SD) | 8.44 ± 1.86 | 8.73 ± 1.89 | 0.24 |
Etiology of cirrhosis (Index admission1) | |||
Alcoholic | 61, 50.83 | 60, 50.00 | 1.00 |
Non-alcoholic fatty liver | 42, 35.00 | 37, 30.83 | 0.58 |
Viral | 21, 17.50 | 22, 18.33 | 1.00 |
Hep B | 1, 4.76 | 3, 13.64 | 0.80 |
Hep C | 19, 90.48 | 18, 81.82 | |
Hep B and C | 1, 4.76 | 1, 4.55 | |
Cryptogenic | 6, 5.00 | 7, 5.83 | 1.00 |
Autoimmune | 1, 0.83 | 1, 0.83 | 1.00 |
Primary sclerosing cholangitis | 2, 1.67 | 2, 1.67 | 1.00 |
Hemochromatosis | 0, 0.0 | 3, 2.5 | 0.25 |
Alpha 1 anti-trypsin deficiency | 3, 2.5 | 0, 0.0 | 0.25 |
Under evaluation for liver transplant | |||
No | 45, 37.50 | 61, 50.83 | 0.08 |
Yes | 63, 52.50 | 53, 44.17 | |
Unknown | 12, 10.00 | 6, 5.00 |
- Citation: Pusateri A, Litzenberg K, Griffiths C, Hayes C, Gnyawali B, Manious M, Kelly SG, Conteh LF, Jalil S, Nagaraja HN, Mumtaz K. Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis. World J Hepatol 2023; 15(6): 826-840
- URL: https://www.wjgnet.com/1948-5182/full/v15/i6/826.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i6.826